Cubist Pharmaceuticals (CBST) 101.94 $CBST Cubist

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 9:07 AM

Cubist Pharmaceuticals (CBST) 101.94 $CBST

Cubist Pharmaceuticals Shares Up 52.7% Since SmarTrend's Buy Recommendation (CBST)
Comtex SmarTrend(R) - Wed Mar 25, 9:59AM CDT
SmarTrend identified an Uptrend for Cubist Pharmaceuticals (NASDAQ:CBST) on October 21st, 2014 at $66.76. In approximately 5 months, Cubist Pharmaceuticals has returned 52.71% as of today's recent price of $101.94.
CBST: 101.94 (+0.14)

52.7% Return Seen to Date on SmarTrend Cubist Pharmaceuticals Call (CBST)
Comtex SmarTrend(R) - Tue Mar 10, 5:08PM CDT
SmarTrend identified an Uptrend for Cubist Pharmaceuticals (NASDAQ:CBST) on October 21st, 2014 at $66.76. In approximately 5 months, Cubist Pharmaceuticals has returned 52.71% as of today's recent price of $101.94.
CBST: 101.94 (+0.14)

Cubist Pharmaceuticals Has Returned 52.7% Since SmarTrend Recommendation (CBST)
Comtex SmarTrend(R) - Mon Feb 09, 11:06AM CST
SmarTrend identified an Uptrend for Cubist Pharmaceuticals (NASDAQ:CBST) on October 21st, 2014 at $66.76. In approximately 4 months, Cubist Pharmaceuticals has returned 52.71% as of today's recent price of $101.94.
CBST: 101.94 (+0.14)

Uptrend Call Working As Cubist Pharmaceuticals Stock Rises 52.7% (CBST)
Comtex SmarTrend(R) - Mon Feb 02, 9:48AM CST
SmarTrend identified an Uptrend for Cubist Pharmaceuticals (NASDAQ:CBST) on October 21st, 2014 at $66.76. In approximately 3 months, Cubist Pharmaceuticals has returned 52.71% as of today's recent price of $101.94.
CBST: 101.94 (+0.14)

Merck concludes tender offer to acquire Cubist at USD102.00 per share
M2 - Thu Jan 22, 5:34AM CST
Healthcare company Merck (NYSE:MRK) said on Wednesday that it has acquired all of the outstanding shares of common stock of Cubist Pharmaceuticals (NasdaqGS:CBST) at a purchase price of USD102.00 per share in a tender offer.
CBSTZ: 0.06 (unch), CBST: 101.94 (+0.14), MRK: 58.66 (+0.23)

Merck Completes Tender Offer to Acquire Cubist
BusinessWire - Wed Jan 21, 7:00AM CST
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the successful completion of the tender offer for all of the outstanding shares of common stock of Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) at a purchase price of $102.00 per share. As of the tender offer expiration yesterday, 58,039,667 shares of common stock of Cubist were validly tendered and not properly withdrawn from the tender offer, representing approximately 75.7 percent of the outstanding common stock of Cubist on a fully diluted basis. All of such shares have been accepted for payment in accordance with the terms of the tender offer, and Merck expects to promptly pay for all such shares.
CBSTZ: 0.06 (unch), CBST: 101.94 (+0.14), MRK: 58.66 (+0.23)

Dana Holding Set to Join the S&P MidCap 400
PR Newswire - Tue Jan 20, 4:45PM CST
Dana Holding Corp. (NYSE: DAN) will replace Cubist Pharmaceuticals Inc. (NASD: CBST) in the S&P MidCap 400 after the close of trading on Thursday, January 22. S&P 100 & 500 constituent Merck & Co. Inc. (NYSE: MRK) is acquiring Cubist Pharmaceuticals in a transaction expected to be completed soon, pending final conditions.
CBSTZ: 0.06 (unch), CBST: 101.94 (+0.14), MRK: 58.66 (+0.23), DAN: 13.64 (+0.05), MHFI: 107.92 (+1.16)

Merck Speeds Up Lung Cancer, HCV Drugs; Filings in 1H15 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 4:10PM CST
Merck (MRK) will seek FDA approval for its combination HCV treatment in the first half of this year and clearance to expand the use of Keytruda in lung cancer patients.
CBST: 101.94 (+0.14), MRK: 58.66 (+0.23), BMY: 74.81 (+0.15)

United Therapeutics - DEKA Ink Deal for Remodulin System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 4:00PM CST
United Therapeutics (UTHR) inked a deal with DEKA for the development of a pre-filled semi-disposable pump system for the subcutaneous delivery of Remodulin injection in pulmonary arterial hypertension patients.
CBST: 101.94 (+0.14), MDT: 87.63 (+0.21), UTHR: 121.01 (+2.02)

Biotech Stocks Technical Data -- Gilead Sciences, ImmunoGen, Exelixis, Cubist Pharma, and Vanda Pharma
PR Newswire - Tue Dec 30, 7:55AM CST
Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), ImmunoGen Inc. (NASDAQ: IMGN), Exelixis Inc. (NASDAQ: EXEL), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), and Vanda Pharmaceuticals Inc. (NASDAQ: VNDA). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, December 29, 2014, ended flat as the Dow Jones Industrial Average finished at 18,038.23, down 0.09% and the NASDAQ Composite ended at previous day's closing of 4,806.91. The S&P 500 finished the session 0.09% higher at 2,090.57. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 803.07, up 0.26%, with the index advancing 7.88% in the previous three months. Register for your complimentary reports on these five stocks at:
CBSTZ: 0.06 (unch), CBST: 101.94 (+0.14), GILD: 79.47 (-1.77), VNDA: 11.40 (-0.10), IMGN: 2.78 (-0.01), EXEL: 9.18 (+0.23)

Spectrum/Ligand Pharma Seek FDA Nod for CE-Melphalan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 4:00PM CST
Spectrum Pharmaceuticals (SPPI) submitted a new drug application to the FDA for Captisol-enabled melphalan (propylene glycol-free) for the multiple myeloma transplant setting.
CBST: 101.94 (+0.14), LGND: 134.88 (-0.01), SPPI: 6.87 (+0.05), BIOD: 0.44 (-0.01)

Tetraphase Hits 52-Week High on Positive Antibiotic Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 11:10AM CST
Shares of Tetraphase Pharmaceuticals, Inc. have been riding high after the company announced positive top-line data from a phase III study evaluating its experimental antibiotic, eravacycline.
TTPH: 4.02 (-0.06), JNJ: 125.23 (+0.77), CBST: 101.94 (+0.14), MRK: 58.66 (+0.23)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ONLYOFFICE 10.0 Boosts AI and Security Features

A Fresh Look at ONLYOFFICE 10.0's Game-Changing Update Outta the gates swinging, ONLYOFFICE dropped their latest 10.0 update. This one ain't just your average software facelift—it's packing some serious heat with AI enhancements, brand spanking new modular apps, and beefed-up security features that'll make anyone dealing with sensitive data breathe a little easier. AI...

NOARK: Powering Data Centers with Global-Local Approach

The High-Stakes Race for Data Center Power These days, if you're not talking about data centers, you're probably a step behind the curve. AI's explosive growth is pushing data center developments across North America like never before. Larger campuses, hefty power densities—it's all happening at a pace that's got everyone scrambling. For folks like NOARK Electric, this...

Zoomlion Boosts Mining Gear Amid Global Revenue Surge

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...

KAPSARC Drives Energy Dialogue at WPC in Riyadh

Defining Energy Horizons in Riyadh Mark those calendars, because as the global energy crowd descends on Riyadh from October 11 to 15, 2026, KAPSARC steps into the spotlight. As the National Partner at the 25th World Petroleum Congress (WPC), they're not just warming the bench—they're playing every position, shaking up the field of energy. Paving the Pathways with...

tm:rw Revolutionizes Retail with Live TikTok Studios

tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...

AI Revenue Missteps Shake Semiconductor Stocks

Nervous Times for Semiconductor Stocks When the semiconductor sector started October like a high-speed train, I thought we might sail through this month without hitting turbulence. But then, in trotted some shaky AI revenue numbers, and bam, the whole sector took a hit off its October highs. The semiconductor stocks, led by giants like Taiwan Semiconductor Manufacturing...

Tchah Sup Kim: A Retrospective at KCCNY in 2026

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

Arrvel's Thermal Printers: Aiming at E-Com Sellers

Arrvel's Thermal Printing Push: An Overview No one would have pegged tiny thermal label printers as game-changers, but here we are. Arrvel's new lineup of thermal printers is shaking up the world for anyone who's ever had to slap on a shipping label or get inventory organized. They're targeting e-commerce folks and small businesses, which sounds like the right move as...

RingConn Smart Ring Gains Key FDA 510(k) Clearance

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...

Amap, Sands China Unleash Tutu Robots for Resort Duty

Tutu Robots Usher in a New Technological Era for Sands China Alright, let's dive into some tech that feels out of a sci-fi movie and see what Sands China and Amap have cooked up as they introduce the Tutu robot dogs to Sands Resorts Macau. These aren't your run-of-the-mill gadgets—they're futuristic tour guides ready to rewire visitor experiences. The delivery ceremony...